Yasushi Ohmi

987 total citations · 1 hit paper
15 papers, 832 citations indexed

About

Yasushi Ohmi is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Yasushi Ohmi has authored 15 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Yasushi Ohmi's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Yasushi Ohmi is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Yasushi Ohmi collaborates with scholars based in Japan, United States and Canada. Yasushi Ohmi's co-authors include Takashi Yahata, Kenji Iwakabe, Takashi Nishimura, Akio Ohta, Hidemitsu Kitamura, Marimo Sato, Masaru Taniguchi, Shin‐Ichiro Nishimura, Kazuyoshi Takeda and Luc Van Kaer and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Yasushi Ohmi

15 papers receiving 817 citations

Hit Papers

The Natural Killer T (NKT... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasushi Ohmi Japan 10 669 165 93 58 53 15 832
Kenji Iwakabe Japan 10 840 1.3× 231 1.4× 93 1.0× 67 1.2× 52 1.0× 16 977
S Habu Japan 9 412 0.6× 98 0.6× 125 1.3× 56 1.0× 70 1.3× 12 642
Egle Šimelyte Finland 11 239 0.4× 90 0.5× 163 1.8× 38 0.7× 32 0.6× 15 563
Alice N. McEvoy Ireland 14 221 0.3× 83 0.5× 143 1.5× 44 0.8× 26 0.5× 17 762
Z Amraoui Belgium 11 342 0.5× 52 0.3× 98 1.1× 81 1.4× 92 1.7× 11 616
Mamata De United States 15 631 0.9× 59 0.4× 107 1.2× 83 1.4× 33 0.6× 22 908
T Oku Japan 12 229 0.3× 93 0.6× 132 1.4× 35 0.6× 24 0.5× 19 554
Michael Diegel United States 11 264 0.4× 32 0.2× 143 1.5× 59 1.0× 35 0.7× 15 549
Nitya Jain United States 10 387 0.6× 128 0.8× 209 2.2× 95 1.6× 48 0.9× 17 708
Ohn A. Chow United States 7 505 0.8× 57 0.3× 240 2.6× 81 1.4× 166 3.1× 10 897

Countries citing papers authored by Yasushi Ohmi

Since Specialization
Citations

This map shows the geographic impact of Yasushi Ohmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Ohmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Ohmi more than expected).

Fields of papers citing papers by Yasushi Ohmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Ohmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Ohmi. The network helps show where Yasushi Ohmi may publish in the future.

Co-authorship network of co-authors of Yasushi Ohmi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Ohmi. A scholar is included among the top collaborators of Yasushi Ohmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Ohmi. Yasushi Ohmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Matsumoto, Goichi, Satoshi Tsunematsu, Keiichi Tsukinoki, et al.. (2002). Essential Role of the Adhesion Receptor LFA-1 for T Cell-Dependent Fulminant Hepatitis. The Journal of Immunology. 169(12). 7087–7096. 24 indexed citations
2.
Matsumoto, Goichi, et al.. (2002). Growth of human squamous cell carcinoma xenografts in mice is inhibited by local angiostatin gene therapy. Oral Oncology. 38(6). 543–548. 4 indexed citations
3.
Matsumoto, Goichi, et al.. (2001). Angiostatin gene therapy inhibits the growth of murine squamous cell carcinoma in vivo. Oral Oncology. 37(4). 369–378. 10 indexed citations
4.
Ohmi, Yasushi, et al.. (1999). Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 × anti-c-ErbB-2 bispecific antibody. Cancer Immunology Immunotherapy. 48(8). 456–462. 4 indexed citations
5.
Nishimura, Takashi, Kenji Iwakabe, Masashi Sekimoto, et al.. (1999). Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo. The Journal of Experimental Medicine. 190(5). 617–628. 18 indexed citations
6.
Yahata, Takashi, Naoko Abe, Yasushi Ohmi, et al.. (1999). The essential role of phorbol ester-sensitive protein kinase C isoforms in activation-induced cell death of Th1 cells. European Journal of Immunology. 29(3). 727–732. 20 indexed citations
7.
Kitamura, Hidemitsu, Kenji Iwakabe, Takashi Yahata, et al.. (1999). The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells. The Journal of Experimental Medicine. 189(7). 1121–1128. 527 indexed citations breakdown →
8.
Yahata, Takashi, Kiyoshi Ando, Kazuhito Watanabe, et al.. (1998). Reconstitution of immune systems in RAG2−/− mice by transfer with interleukin-12-induced splenic hematopoietic progenitor cells. Immunology Letters. 62(3). 165–170. 1 indexed citations
9.
Iwakabe, Kenji, Masako Shimada, Akio Ohta, et al.. (1998). The restraint stress drives a shift in Th1/Th2 balance toward Th2-dominant immunity in mice. Immunology Letters. 62(1). 39–43. 104 indexed citations
10.
Yahata, Takashi, Kazuhito Watanabe, Akio Ohta, et al.. (1998). Accumulation of IL-12-activated antitumor effector cells into lymph nodes of tumor-bearing mice. Immunology Letters. 61(2-3). 127–133. 5 indexed citations
11.
Ohta, Akio, Naoko Sato, Takashi Yahata, et al.. (1997). Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen-specific Th1 or Th2 cells. Journal of Immunological Methods. 209(1). 85–92. 29 indexed citations
12.
Nishimura, Takashi, Kazuki Santa, Takashi Yahata, et al.. (1997). Involvement of IL-4-producing Vbeta8.2+ CD4+ CD62L- CD45RB- T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice. The Journal of Immunology. 158(12). 5698–5706. 51 indexed citations
13.
Ohmi, Yasushi, Akio Ohta, Naoko Sato, et al.. (1997). The Role of Phorbol Ester-Sensitive Protein Kinase C Isoforms in Lymphokine-Activated Killer Cell-Mediated Cytotoxicity: Dissociation between Perforin-Dependent and Fas-Dependent Cytotoxicity. Biochemical and Biophysical Research Communications. 235(3). 461–464. 9 indexed citations
14.
Sato, Naoko, Takashi Yahata, Kazuki Santa, et al.. (1996). Functional characterization of NK1.1+ Ly-6C+ cells. Immunology Letters. 54(1). 5–9. 25 indexed citations
15.
Tanaka, Shoma, Atsuko Fujihara, Mizuki Yamamoto, et al.. (1994). [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].. PubMed. 21(2). 219–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026